ONXX Related Analyst EPS Change
-
Brean Capital Raises Onyx (ONXX) Price Target to $115
-
Jefferies Lifts PT on Onyx Pharmaceuticals (ONXX) to $104
-
Jefferies Trims PT on Onyx Pharmaceuticals (ONXX) Post Q4
-
Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Raising Kyprolis Estimates
-
Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
-
Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies
-
Barclays Raises Price Target on Onyx Pharmaceuticals (ONXX); Kyprolis Gets Surprisingly Supportive Commentary
-
Jefferies Adjusts Estimates and Price Target on Onyx Pharmaceuticals (ONXX); Downside Scenarios Reviewed
-
Brean Murray Carret & Co. Upgrades Onyx Pharmaceuticals (ONXX) to Buy; Misleading Documents...FDA Approval Is Coming
-
Goldman Sachs Raises Price Target on Onyx Pharma (ONXX) after FDA Panel Backs CFZ
-
Barclays Maintains an 'Equalweight' on Onyx Pharmaceuticals (ONXX); Facing Uphill Battle
-
Goldman Sachs Removes Onyx Pharmaceuticals (ONXX) from Conviction Buy List
Back to ONXX Stock Lookup
